A major difficulty in treating cancer is the inability to differentiate
A major difficulty in treating cancer is the inability to differentiate between normal and tumor cells. affinity and specificity. One Fab, fE75, recognizes our model malignancy marker, the Human Epidermal growth factor Receptor 2 (HER2/neu) peptide, At the75, 955365-80-7 bound to the MHC called Human Leukocyte Antigen-A2 (HLA-A2), with nanomolar affinity. The fE75 bound selectively … [Read more…]